Skip to content

Prevention of anastomotic leakage in colorectal surgery with a biodegradable drain.

Colorectal anastomosis proteced by a biodegradable drain fixed to the anastomosis by a circular stapler: A Multi-Center Randomized Controlled Trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON27437
Enrollment
618
Registered
2011-09-26
Start date
2011-10-15
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Surgery Anastomotic Leakage C-Seal Drain

Interventions

Use of the C-Seal drain. The C-seal is a biodegradable thin-walled drain. It is compatible with the circular stapler used in almost all low anterior resections. It is developed to prevent extravasati

Sponsors

UMC Groningen, Dept. of Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Any colorectal disease requiring a colorectal anastomosis to be made by a circular stapler/cutter; 2. Elective surgery; 3. Age > 18 years; 4. American Society of Anesthesiologists (ASA) classification 1, 2 or 3; 5. No clinical signs of peritonitis; 6. No major surgical or interventional procedures within 30 days prior to this study or planned surgical or interventional procedures within 30 days of entry into this study; 7. Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial; 8. Written informed consent must be signed according to ICH/GCP and Dutch law, before patient registration and randomization; 9. Patients can only be randomized in this trial once.

Exclusion criteria

Exclusion criteria: No specific exclusion criteria other than the opposite of the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the incidence of anastomotic leakage leading to invasive treatment within 30 days after the primary operation. 1. Anastomotic leakage is defined as a communication between the intra- and extraluminal compartments owing to a defect of the integrity of the intestinal wall at the anastomosis; 2. An abscess in the proximity of the anastomosis is considered as AL; 3. Invasive treatment is defined as any invasive procedure after the primary operation: Surgical treatment in the operating theatre or radiological drainage.

Secondary

MeasureTime frame
1. Number of dismantled anastomoses; 2. Grade A, B or C AL within 30 days after the primary operation; 3. The interval between the primary operation and the diagnosis of AL; 4. Pain score at day 3 postoperatively on a Visual Analogue Scale; 5. The number of ostomies created; 6. Late anastomotic leakage (diagnosed ≥30 days and within 1 year postoperative); 7. The number of ostomies present after one year; 8. The total duration of hospital stay including readmissions for (serious) adverse events and/or stoma closure; 9. The interval between the primary operation and the excretion of the C-seal through the anus; 10. Interval between C-seal application and C-seal loss; 11. Other complications.

Contacts

Public ContactI.S. Bakker

Afdeling Chirurgie Universitair Medisch Centrum Groningen Postbus 30001

i.s.bakker@umcg.nl+31 (0)6 18151429

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)